Study: The blockage of the neck area may not require surgical intervention

A study conducted in Europe and Canada showed that many people with density in the arteries of the neck may not need surgical interventions to prevent the risk of strokes, which are the usual procedures currently being followed to handle this condition. In the United States alone, more than 100,000 surgeries are performed annually to remove obstruction in the carotis artery, and in many cases it was found that removing the cul -de -sac of the blood vessel reduces the risk of stroke, but the procedure itself can stimulate its incidence. In addition to surgery or intervention by installing a pillar, patients receive bloodshed and blood pressure medication and cholesterol levels. Given the improvement of this medication over the years, the researchers have asked if routine reins in cases of blocking the carotis artery are still needed in all cases. The narrowing of the carotist artery and the researchers in the study used about 429 patients, most of whom are the elderly, suffer from a narrowing of the carotist artery by at least 50%, but the possibility of their stroke is not high and is less than 20%. All the study participants received the usual medication, and the researchers randomly distributed in two groups, the first underwent surgery, and the other for the installation of support. The study, published in the Medical Journal (The Lancer Neurology), showed that the researchers did not notice the differences in the rate of strokes, heart attacks or death after two years. It comes regardless of the suffering of patients due to the symptoms of the narrowing of the carotis artery, such as feeling sudden weakness, numbness on one side of the body, or problems of understanding and talking, or sudden loss of vision and confusion of vision or dizziness. In an article published with the study, it is said that researchers will continue to follow the participants in the experiment for three years, and expect the results that will appear at that time to be more reliable. Dr. Paul Nadcorn, from the Center for Amsterdam Medical University, who participated in the leadership of the studies team, said in a statement that the results are currently indicating that the medicine is likely to be alone to reduce the risk of stroke at 75% of patients.